• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?疫苗犹豫是否会影响我们应对下一波 SARS-CoV-2 疫情的努力?
Hum Vaccin Immunother. 2021 Jun 3;17(6):1664-1665. doi: 10.1080/21645515.2020.1829413. Epub 2020 Nov 12.
2
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.13价肺炎球菌结合疫苗在70岁及以上曾接种23价肺炎球菌多糖疫苗的成年人中的免疫原性和安全性。
Vaccine. 2013 Aug 2;31(35):3585-93. doi: 10.1016/j.vaccine.2013.05.010. Epub 2013 May 18.
3
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults.在未接种过肺炎球菌疫苗的成年人中,13价肺炎球菌结合疫苗与23价肺炎球菌多糖疫苗的免疫原性和安全性比较
Vaccine. 2013 Aug 2;31(35):3577-84. doi: 10.1016/j.vaccine.2013.04.085. Epub 2013 May 18.
4
Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial.在先前已接种过多糖型肺炎球菌疫苗 23 价的成年人中联合使用 13 价肺炎球菌结合疫苗和四价灭活流感疫苗:一项随机临床试验。
Hum Vaccin Immunother. 2019;15(2):444-451. doi: 10.1080/21645515.2018.1533777. Epub 2018 Oct 25.
5
Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults.成人序贯接种 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗 1 年后抗体的持久性。
Hum Vaccin Immunother. 2019;15(3):575-583. doi: 10.1080/21645515.2018.1538618. Epub 2019 Jan 16.
6
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.13价肺炎球菌结合疫苗(PCV13)在6至17岁曾接种23价肺炎球菌多糖疫苗(PPSV23)的镰状细胞病患儿中具有免疫原性且安全:一项3期研究的结果
Pediatr Blood Cancer. 2015 Aug;62(8):1427-36. doi: 10.1002/pbc.25502. Epub 2015 Mar 23.
7
Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group.肺炎球菌结合疫苗在慢性淋巴细胞白血病患者中引发的免疫应答优于肺炎球菌多糖疫苗:一项由瑞典 CLL 研究组开展的随机研究。
Vaccine. 2018 Jun 14;36(25):3701-3707. doi: 10.1016/j.vaccine.2018.05.012. Epub 2018 May 7.
8
Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age.60-64 岁未曾接种过肺炎球菌疫苗的成年人中序贯接种 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗。
Vaccine. 2014 Apr 25;32(20):2364-74. doi: 10.1016/j.vaccine.2014.02.002. Epub 2014 Mar 5.
9
Prevention of Coronavirus Disease 2019 Among Older Adults Receiving Pneumococcal Conjugate Vaccine Suggests Interactions Between Streptococcus pneumoniae and Severe Acute Respiratory Syndrome Coronavirus 2 in the Respiratory Tract.预防老年人 2019 年冠状病毒病使用肺炎球菌结合疫苗提示呼吸道中肺炎链球菌与严重急性呼吸综合征冠状病毒 2 之间的相互作用。
J Infect Dis. 2022 May 16;225(10):1710-1720. doi: 10.1093/infdis/jiab128.
10
Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial.23 价肺炎球菌多糖疫苗与 4 价流感疫苗同时与序贯接种在老年人中的免疫原性:一项随机、开放标签、非劣效性试验。
Hum Vaccin Immunother. 2018;14(8):1923-1930. doi: 10.1080/21645515.2018.1455476. Epub 2018 May 14.

引用本文的文献

1
Vaccine hesitancy in healthcare workers during COVID-19 pandemic: Draw on experience.新冠疫情期间医护人员的疫苗犹豫:借鉴经验
J Prev Med Hyg. 2025 May 31;66(1):E1-E8. doi: 10.15167/2421-4248/jpmh2025.66.1.3297. eCollection 2025 Mar.
2
Recent changes to adult national immunization programs for pneumococcal vaccination in Europe and how they impact coverage: A systematic review of published and grey literature.近期欧洲成人国家免疫计划中肺炎球菌疫苗接种的变化及其对覆盖率的影响:对已发表和灰色文献的系统评价。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2279394. doi: 10.1080/21645515.2023.2279394. Epub 2023 Nov 28.
3
Determinants of COVID-19 vaccine behaviour intentions among the youth in Kenya: a cross-sectional study.肯尼亚青年中新冠病毒疫苗接种行为意向的决定因素:一项横断面研究
Arch Public Health. 2022 Jun 23;80(1):159. doi: 10.1186/s13690-022-00904-4.
4
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination.从新冠病毒感染中康复的意大利患者对流感和新冠病毒疫苗接种的犹豫态度
Vaccines (Basel). 2021 Feb 18;9(2):172. doi: 10.3390/vaccines9020172.

本文引用的文献

1
Seasonal influenza vaccination during a pandemic.季节性流感疫苗接种在大流行期间。
Hum Vaccin Immunother. 2020 Sep 1;16(9):2219-2221. doi: 10.1080/21645515.2020.1793713. Epub 2020 Jul 31.
2
Eight years of active proposal of pneumococcal 23-valent polysaccharide vaccine: survey on coverage rate among elderly and chronic patients.8 年积极推广肺炎球菌 23 价多糖疫苗:老年和慢性病患者接种率调查。
Am J Infect Control. 2010 May;38(4):e8-e15. doi: 10.1016/j.ajic.2009.09.019. Epub 2010 Mar 7.

疫苗犹豫是否会影响我们应对下一波 SARS-CoV-2 疫情的努力?

Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?

机构信息

Department of Health Sciences (Dissal), University of Genoa, Genoa, Italy.

Hygiene Unit, IRCCS Policlinico San Martino Hospital, Genoa, Italy.

出版信息

Hum Vaccin Immunother. 2021 Jun 3;17(6):1664-1665. doi: 10.1080/21645515.2020.1829413. Epub 2020 Nov 12.

DOI:10.1080/21645515.2020.1829413
PMID:33180669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8115564/
Abstract

We have checked the vaccination history of 389 elderly patients (62.9% males, mean age of 78.5 + 8.4 years) hospitalized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Information regarding pneumococcal vaccination was available for 354 patients (91.0%): the overall vaccination coverage rate (VCR) was 19.8% (70/354), 11.3% received only 13-valent pneumococcal conjugate vaccine (PCV13), 3.4% were immunized with 23-valent pneumococcal polysaccharide vaccine (PPSV23), 5.1% received both vaccines. VCR among the elderly population in Liguria Region was 26.2% (118,581/453,082), among them 13.7% received PCV13, 12.4% were immunized with at least one dose of PPSV23. Regarding the 2019-2020 influenza season vaccination data were available for 46 patients: 59% of them were immunized. VCR in the elderly population was 51.7% (234,153/453,082).

摘要

我们检查了 389 名因严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 肺炎住院的老年患者(62.9%为男性,平均年龄为 78.5+8.4 岁)的疫苗接种史。有 354 名患者(91.0%)可提供有关肺炎球菌疫苗接种的信息:总体疫苗接种覆盖率(VCR)为 19.8%(70/354),11.3%仅接种了 13 价肺炎球菌结合疫苗(PCV13),3.4%接种了 23 价肺炎球菌多糖疫苗(PPSV23),5.1%同时接种了这两种疫苗。利古里亚地区老年人的 VCR 为 26.2%(118,581/453,082),其中 13.7%接种了 PCV13,12.4%至少接种了一剂 PPSV23。关于 2019-2020 年流感季节的疫苗接种数据,有 46 名患者可查:其中 59%的人已接种。老年人的 VCR 为 51.7%(234,153/453,082)。